22 / 78
116
Ces Urol 2015; 19(2): 106–117
PŘEHLEDOVÝ ČLÁNEK
5. Hora M, Ürge T, Kalusová K, Michal M, et al.
Novelizovaná klasifikace nádorů ledvin 2013 (International
society of urological pathology Vancouver classification of renal neoplasia). Ces Urol 2014; 18(1): 9–20.
6. Zedebin D, Kammerhober F, Uggowitzer MM, Szolar DH.
Criteria for ultrasound differentiation of
small angiomyolipomas ( <3cm) and renal cell carcinomas. RoFo Forschr Geb Rontgenster Neuen Bilgeb
Verfahr 1998; 169: 627–632.
7. Tanaka H, Yoshida S, Fujii Y, et al.
Diffusion-weighted magnetic resonance imaging in the differentiation
of angiomyolipoma with minimal fat from clear cell renal cell carcinoma. Int J Urol. 2011 Oct; 18 (10): 727–308.
8. Halpenny D, Snow A, McNeill G, Torreggiani WC.
The radiological diagnosis and treatment of renal
angiomyolipoma – current status. Clinical Radiology 2010; 65: 99–108.
9. Mues AC, Palacios JM, Haramis G, et al.
Contemporary experience in the management of angiomyo-
lipoma. J Endourol 2010 Nov; 24(11): 1883–1886.
10. Eble JN, Sauter G, Epstein JI, et al.
(eds). Pathology and genetics of tumours of the urinary system and
male genital organs. World Health Organization Classification of Tumours. Lyon: IARC Press, 2004: 9–87.
11. Oesterling JE, Fishman EK, Goldman SM, Marshall FF.
The management of renal angiomyolipoma.
J Urol 1986; 135: 1121–1124.
12. Nelson CP, Sanda MG.
Contemporary diagnosis and management of renal angiomyolipoma. J Urol 2002.
Oct; 168 (4 Pt 1): 1315–1325.
13. Sooriakumaran P, Gibbs P, Coughlin G, et al.
Angiomyolipomata: challenges, solutions, and future
prospects based on over 100 cases treated. BJU Int. 2010; 105(1): 101–106.
14. Ouzaid I, Autorino R, Fatica R, et al.
Active surveillance for renal angiomyolipoma: outcomes and
factors predictive of delayed intervention. BJU Int. 2014 Sep; 114 (3): 412–417.
15. Sýkora R, Fabišovský M, Němec D, Vašík J, Krhut J.
Život ohrožující krvácení do dutiny břišní na pod-
kladě spontánní ruptury angiomyolipomu. Ces Urol 2013; 17(1): 51–54.
16. Dickinson M, Ruckle H, Beaghler M, Hadley HR.
Renal angiomyolipoma: optimal treatment based
on size and symptoms. Clin Nephrol. 1998; 49(5): 281–286.
17. Yamakado K, Tanaka N, Nakawaga T, et al.
Renal angiomyolipoma: relationships between tumour
size, aneurysm formation and ruptute. Radiology 2002; 225: 78–82.
18. Han YM, Kim JK, Roh BS, et al.
Renal angiomyolipoma: selective arterial embolization-effectiveness
and changes in angiomyogenic components in long-term follow-up. Radiology. 1997; 204(1): 65–70.
19. Ramon J, Rimon U, Garniek A, et al.
Renal angiomyolipoma: long-term results following selective
arterial embolization. Eur Urol 2009 May; 55(5): 1155–1161.
19. Kothary N, McClarc S, Clark TW, et al.
Ranal angiomyolipoma: long term results after arterial emboli-
zation. J Vasc Interv Radiol 2005; 16(1): 45–50.
20. Ewalt DH, Diamond N, Rees C, et al.
Long-term outcome of transcatheter embolization of renal an-
giomyolipomas due to tuberous sclerosis complex. J Urol. 2005; 174(5): 1764–1766.
21. Chi Kwok Chan, Simon Yu, Sidney Yip, and Paul Lee.
The efficacy, safety and durability of selective
renal arterial embolization in treating symptomatic and asymptomatic renal angiomyolipoma. UROLOGY
2011; 77(3): 641–648.
22. Stránský P, Chudáček Z, Havel V, et al.
Možnosti intervenční radiologie při léčbě nádorů ledvin. Ces
Urol 2012; 16(1): 50–57.
23. Bishay VL, Crino PB, Wein AJ, et al.
Embolization of giant renal angiomyolipomas: technique and
results. J Vasc Interv Radiol. 2010; 21(1): 67–72.
24. Hocquelet A, Cornelis F, Le Bras Y, et al.
Long-term results of preventive embolization of renal angio-
myolipomas: evaluation of predictive factors of volume decrease. Eur Radiol. 2014 Aug; 24(8): 1785–1793.
25. Prevoo W, van den Bosch MA, Horenblas S.
Radiofrequency ablation for treatment of sporadic an-
giomyolipoma. Urology. 2008; 72(1): 188–191.